Children with lymphadenitis associated with Bacillus Calmette-Guérin (BCG) vaccination do not experience more infections when compared with BCG-vaccinated children without lymphadenitis: a three years paired-cohort in Mexico
- PMID: 29201375
- PMCID: PMC5697593
- DOI: 10.1177/2051013617741585
Children with lymphadenitis associated with Bacillus Calmette-Guérin (BCG) vaccination do not experience more infections when compared with BCG-vaccinated children without lymphadenitis: a three years paired-cohort in Mexico
Abstract
Objectives: Vaccination against tuberculosis with live-attenuated Bacillus Calmette-Guérin (BCG) is widely used even though its effectiveness is controversial. BCG-lymphadenitis (BCG-LA) is its most common complication. Some studies have proposed that BCG-LA can be associated with primary immunodeficiencies (PIs). This study's aim is to see whether patients who developed BCG-LA (named as 'LA') developed more infections than BCG-vaccinated children without BCG-LA (named as 'NON-LA').
Methods: From January 2009 to April 2014, 31 LA children were seen at the outpatient clinic of the General Hospital of Tijuana, Mexico. Among them, 22 (70.97%), 5 (16.13%) and 4 (12.9%) had axillary, supraclavicular, or both BCG-LA, respectively. No treatment was given and complications were not seen. Per LA subject, a NON-LA not >1 month of age difference and same gender was paired and followed for 3 years to look for ambulatory infections (AINFs), acute otitis media (AOM) and hospitalizations. Surveillance per patient was performed by phone monthly, and they were seen at the clinic every 4 months. All patients were HIV-negative and had no family history of PI. Statistical analyses used were relative risk (RR) with confidence intervals (CI), t test for independent variables and z test.
Results: In total 62 subjects were enrolled: 31 LA paired with 31 NON-LA. Between them, there were no differences in age, day care attendance and breastfeeding. There were no differences in the total number of AINF per patient (LA: 18.61 avg. ± 5.03 SD versus NON-LA: 18.19 avg. ± 4.17 SD, RR = 1.06, 95% CI = 0.33-0.66), AOM total episodes (LA: 30 versus NON-LA: 26, RR = 0.87, 95% CI = 0.31-0.68) and hospitalizations (LA: 5 versus NON-LA: 4, RR = 1, 95% CI = 0.25-0.74).
Conclusions: This cohort strongly suggests that BCG-LA in healthy children is not associated with more episodes of AINF and hospitalizations, when paired and compared with children BCG-vaccinated without BCG-LA.
Keywords: Bacillus Calmette-Guerin, BCG; Children; Lymphadenitis; Primary Immunodficiencies.
Conflict of interest statement
Conflict of interest statement: The authors declare that there is no conflict of interest.
Figures
Similar articles
-
Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.Saudi Med J. 2012 Feb;33(2):172-6. Saudi Med J. 2012. PMID: 22327758
-
Incidence of lymphadenitis following Bacillus Calmette-Guérin (BCG) vaccination in north Indian children.Indian J Tuberc. 2022 Oct;69(4):596-601. doi: 10.1016/j.ijtb.2021.09.008. Epub 2021 Sep 24. Indian J Tuberc. 2022. PMID: 36460395
-
[Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):569-72. Ned Tijdschr Geneeskd. 2003. PMID: 12693089 Dutch.
-
Bacillus Calmette-Guérin vaccination at birth: Effects on early childhood infections, growth, and development.Dan Med J. 2016 Nov;63(11):B5304. Dan Med J. 2016. PMID: 27808041 Review.
-
Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.JAMA Pediatr. 2019 Jan 1;173(1):75-85. doi: 10.1001/jamapediatrics.2018.4038. JAMA Pediatr. 2019. PMID: 30476973 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous